Literature DB >> 11533082

Multifocal squamous cell carcinoma of the oesophagus following radiotherapy for bilateral breast carcinoma.

S Shousha1, A Fawcett, Y A Luqmani, N Theodorou.   

Abstract

A 60 year old woman who presented with dysphagia and weight loss was found to have multiple foci of dysplasia and in situ and invasive squamous cell carcinoma scattered along the whole length of the oesophagus, with intervening areas of normal mucosa. The patient had a history of two breast carcinomas 19 and one year previously for which she had repeated radiotherapy. Several members of the patient's close family had histories of malignant disease. All oesophageal lesions and the more recent breast cancer showed positive immunostaining for p53 protein. p53 mutations, some involving different exons, were also detected in these lesions. No p53 immunostaining or mutations were detected in the normal oesophageal mucosa. The findings suggest an independent origin of the multiple dysplastic and neoplastic foci, which might have developed in a background of a field change, possibly related to the previous radiotherapy. The strong family history of malignant diseases raises the possibility that, in addition, genetic factors might have played a role in the development of the oesophageal disease.

Entities:  

Mesh:

Year:  2001        PMID: 11533082      PMCID: PMC1731515          DOI: 10.1136/jcp.54.9.718

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  Second malignancies after breast cancer: the impact of different treatment modalities.

Authors:  Y M Kirova; Y De Rycke; L Gambotti; J-Y Pierga; B Asselain; A Fourquet
Journal:  Br J Cancer       Date:  2008-02-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.